Cargando…

ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185

It has been reported that the expression of zinc finger protein 139 (ZNF139) and microRNA-185 (miR-185) were associated with proliferation, drug resistance of gastric cancer (GC) cells. However, the detailed mechanisms have not been fully investigated. The expression of ZNF139 in both GC tissues and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Bibo, Li, Yong, Zhao, Qun, Fan, Liqiao, Wang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123064/
https://www.ncbi.nlm.nih.gov/pubmed/30126848
http://dx.doi.org/10.1042/BSR20181023
_version_ 1783352783799320576
author Tan, Bibo
Li, Yong
Zhao, Qun
Fan, Liqiao
Wang, Dong
author_facet Tan, Bibo
Li, Yong
Zhao, Qun
Fan, Liqiao
Wang, Dong
author_sort Tan, Bibo
collection PubMed
description It has been reported that the expression of zinc finger protein 139 (ZNF139) and microRNA-185 (miR-185) were associated with proliferation, drug resistance of gastric cancer (GC) cells. However, the detailed mechanisms have not been fully investigated. The expression of ZNF139 in both GC tissues and cell lines was tested, then SGC7901/ADR or SGC7901 cells were transfected with ZNF139-siRNA, miR-185 analog, or pcDNA-ZNF139. Cell activity was determined by MTT assay. Real-time PCR and Western blot were utilized to detect ZNF139, miR-185, and multidrug resistance (MDR) related genes including MDR1/P-gp, GST-π, MRP-1, Bcl-2, TS and Bax. ChIP and dual luciferase activity assay were used to investigate regulation between ZNF139 and miR-185. Increased ZNF139 and decreased miR-185 expression were detected in GC tissues and cell lines. Transfection with ZNF139-siRNA into SGC7901/ADR cells markedly increased expression of miR-185, and treating with chemotherapeutic drugs ADR, 5-FU, L-OHP, the survival rate of SGC7901/ADR cells obviously decreased after ZNF139-siRNA transfection. On the other hand, transfection with pcDNA-ZNF139 in GC cell line SGC7901 resulted in an increased expression level of ZNF139 and a decline in the expression level of miR-185, meanwhile drug resistance of GC cells was clearly enhanced to ADR, 5-FU, L-OHP. Dual luciferase activity assay demonstrated that ZNF139 inhibited transcriptional activities of miR-185’s promoter in cells transfected with the reporter plasmid encompassing the upstream promoter region of miR-185 along with pcDNA-ZNF139. Our data reveal that ZNF139 might promote MDR gene MDR1/P-gp, MRP-1 and Bcl-2 by prohibiting miR-185.
format Online
Article
Text
id pubmed-6123064
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-61230642018-09-10 ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185 Tan, Bibo Li, Yong Zhao, Qun Fan, Liqiao Wang, Dong Biosci Rep Research Articles It has been reported that the expression of zinc finger protein 139 (ZNF139) and microRNA-185 (miR-185) were associated with proliferation, drug resistance of gastric cancer (GC) cells. However, the detailed mechanisms have not been fully investigated. The expression of ZNF139 in both GC tissues and cell lines was tested, then SGC7901/ADR or SGC7901 cells were transfected with ZNF139-siRNA, miR-185 analog, or pcDNA-ZNF139. Cell activity was determined by MTT assay. Real-time PCR and Western blot were utilized to detect ZNF139, miR-185, and multidrug resistance (MDR) related genes including MDR1/P-gp, GST-π, MRP-1, Bcl-2, TS and Bax. ChIP and dual luciferase activity assay were used to investigate regulation between ZNF139 and miR-185. Increased ZNF139 and decreased miR-185 expression were detected in GC tissues and cell lines. Transfection with ZNF139-siRNA into SGC7901/ADR cells markedly increased expression of miR-185, and treating with chemotherapeutic drugs ADR, 5-FU, L-OHP, the survival rate of SGC7901/ADR cells obviously decreased after ZNF139-siRNA transfection. On the other hand, transfection with pcDNA-ZNF139 in GC cell line SGC7901 resulted in an increased expression level of ZNF139 and a decline in the expression level of miR-185, meanwhile drug resistance of GC cells was clearly enhanced to ADR, 5-FU, L-OHP. Dual luciferase activity assay demonstrated that ZNF139 inhibited transcriptional activities of miR-185’s promoter in cells transfected with the reporter plasmid encompassing the upstream promoter region of miR-185 along with pcDNA-ZNF139. Our data reveal that ZNF139 might promote MDR gene MDR1/P-gp, MRP-1 and Bcl-2 by prohibiting miR-185. Portland Press Ltd. 2018-09-05 /pmc/articles/PMC6123064/ /pubmed/30126848 http://dx.doi.org/10.1042/BSR20181023 Text en © 2018 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Tan, Bibo
Li, Yong
Zhao, Qun
Fan, Liqiao
Wang, Dong
ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
title ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
title_full ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
title_fullStr ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
title_full_unstemmed ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
title_short ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
title_sort znf139 increases multidrug resistance in gastric cancer cells by inhibiting mir-185
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123064/
https://www.ncbi.nlm.nih.gov/pubmed/30126848
http://dx.doi.org/10.1042/BSR20181023
work_keys_str_mv AT tanbibo znf139increasesmultidrugresistanceingastriccancercellsbyinhibitingmir185
AT liyong znf139increasesmultidrugresistanceingastriccancercellsbyinhibitingmir185
AT zhaoqun znf139increasesmultidrugresistanceingastriccancercellsbyinhibitingmir185
AT fanliqiao znf139increasesmultidrugresistanceingastriccancercellsbyinhibitingmir185
AT wangdong znf139increasesmultidrugresistanceingastriccancercellsbyinhibitingmir185